Shandong Xinhua Pharmaceutical Company Limited (XIN) — Strategic Asset Allocation Index
Shandong Xinhua Pharmaceutical Company Limited (XIN) has a Strategic Asset Allocation Index of 84.9% as of September 2023. Strategic assets (PP&E of €3.99 Billion plus long-term investments of €-) total €3.99 Billion, measured against net assets of €4.70 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Shandong Xinhua Pharmaceutical Company L balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Shandong Xinhua Pharmaceutical Company Limited Strategic Asset Allocation Index (2013–2022)
This chart shows how Shandong Xinhua Pharmaceutical Company Limited's Strategic Asset Allocation Index has evolved across 10 annual periods from 2013 to 2022. As of September 2023, the index stands at 84.9%, representing strategic assets of €3.99 Billion against net assets of €4.70 Billion EUR. For live market cap and overall valuation, see Shandong Xinhua Pharmaceutical Company L (XIN) total market value.
Annual Strategic Asset Allocation Index for Shandong Xinhua Pharmaceutical Company Limited (2013–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Shandong Xinhua Pharmaceutical Company Limited from 2013 to 2022, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See shareholders equity of Shandong Xinhua Pharmaceutical Company L for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 92.0% | €4.00 Billion | €4.00 Billion | €- | €4.35 Billion | ▼ -11.2 pp |
| 2021 | 103.1% | €3.77 Billion | €3.77 Billion | €- | €3.65 Billion | ▼ -1.2 pp |
| 2020 | 104.4% | €3.54 Billion | €3.54 Billion | €- | €3.39 Billion | ▼ -8.1 pp |
| 2019 | 112.4% | €3.50 Billion | €3.20 Billion | €296.25 Million | €3.11 Billion | ▲ +1.9 pp |
| 2018 | 110.6% | €3.09 Billion | €2.90 Billion | €189.74 Million | €2.80 Billion | ▲ +0.2 pp |
| 2017 | 110.3% | €2.85 Billion | €2.59 Billion | €258.14 Million | €2.58 Billion | ▼ -14.0 pp |
| 2016 | 124.3% | €2.58 Billion | €2.40 Billion | €189.47 Million | €2.08 Billion | ▲ +2.0 pp |
| 2015 | 122.3% | €2.43 Billion | €2.23 Billion | €200.43 Million | €1.98 Billion | ▼ -1.9 pp |
| 2014 | 124.2% | €2.37 Billion | €2.15 Billion | €220.59 Million | €1.91 Billion | ▲ +11.6 pp |
| 2013 | 112.5% | €2.12 Billion | €1.99 Billion | €127.41 Million | €1.88 Billion | — |